Konstantinos Xynos
Chief Medical Officer · Replimune Group, Inc.
- 2024
- Aug 12, 2026
- 5
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Konstantinos Xynos files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BAKER BROS. ADVISORS LP - $33.00M in REPL purchases and sales in the last 12 months
- Sushil Patel - $811K in REPL purchases and sales in the last 12 months
- Emily Luisa Hill - $320K in REPL purchases and sales in the last 12 months
- Christopher Sarchi - $254K in REPL purchases and sales in the last 12 months
- Andrew Schwendenman - $139K in REPL purchases and sales in the last 12 months
- Philip Astley-Sparke - $90K in REPL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Konstantinos Xynos?
Konstantinos Xynos is a corporate insider, tracked as Chief Medical Officer of Replimune Group, Inc. (REPL). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Konstantinos Xynos submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Konstantinos Xynos been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($364K) across all tracked filings.
